Balovaptan

Unassigned

New Medicines

Autism spectrum disorder (ASD)

Information

New molecular entity
Roche
Roche

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Apr 20 · Balovaptan removed from Roche pipeline after PIII study was stopped in the first quarter after a pre-planned futility analysis. Development discontinued. [8,9]

Category

Vasopressin 1a (V1a) receptor antagonist
It is estimated that about 1% of adults have ASD. The prevalence in children is also around 1%. ASD is more commonly diagnosed in boys than in girls, with a ratio of approximately 4:1, although this varies across the spectrum of ASD. [1]
Autism spectrum disorder (ASD)
Oral